Zymeworks (ZYME) Long-Term Investments (2021 - 2026)

Zymeworks has reported Long-Term Investments for 6 years, with the latest figure at $39.1 million in Q1 2026.

• Quarterly Long-Term Investments fell 30.55% year-over-year to $39.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.1 million (down 30.55% YoY) and the FY2025 annual result came in at $41.8 million, down 57.55% from the prior year.
• Long-Term Investments eased to $39.1 million in Q1 2026 per ZYME's latest filing, from $41.8 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $98.4 million in Q4 2024 and troughed at $886000.0 in Q3 2022.
• A 5-year average of $59.9 million and a median of $65.8 million in 2024 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2023 and 2025: Long-Term Investments surged 10698.42% in 2023, then slumped 57.55% in 2025.
• Over 5 years, Long-Term Investments stood at $886000.0 in 2022, then soared by 9147.18% to $81.9 million in 2023, then increased by 20.14% to $98.4 million in 2024, then slumped by 57.55% to $41.8 million in 2025, then retreated by 6.39% to $39.1 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $39.1 million, $41.8 million, and $47.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.